Cancer Channel
Related Channels

Generic Kyprolis

Patents and exclusivity rights currently prevent any company from making a generic Kyprolis (carfilzomib) product. The earliest predictable date that a generic version could become available is April 2025, when the first patent is set to expire. Although carfilzomib is sometimes called the "generic name" of Kyprolis, it is simply the active ingredient in the medication and not a generic version of it.


Can I Buy Generic Kyprolis?

Kyprolis™ (carfilzomib) is a prescription medicine used to treat people with multiple myeloma, a type of cancer that starts in cells in the bone marrow. It is used in people who did not adequately respond to certain other medications.
Kyprolis is made by DSM Pharmaceuticals, Inc., for Onyx Pharmaceuticals, Inc. It is currently protected by patents and exclusivity rights that prevent any generic Kyprolis from being manufactured in the United States.

When Will a Generic Version Be Available?

The first patent for Kyprolis is set to expire in April 2025. This is the earliest possible date that a generic version could become available.

However, other circumstances could come up to delay or shorten this exclusivity period. This could include things such as lawsuits or other patents for new Kyprolis uses. Once the patent expires, several companies may begin manufacturing a generic Kyprolis drug.

Is Carfilzomib a Generic Kyprolis?

No, carfilzomib is the active ingredient in Kyprolis, not a generic version of it. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name."

The generic name is different from a generic version of a medicine. In order for there to be a generic version, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.
7 Natural Ways to Reduce Your Cancer Pain

Kyprolis Chemotherapy Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.